Brodsky & Smith LLC is investigating whether the boards of Silence Therapeutics, Option Care Health, RXO Inc., and Sangoma Technologies breached their fiduciary duties in recent merger deals. Each investigation questions if the companies' boards conducted fair processes and offered fair value to shareholders in their respective acquisitions. These mergers involve significant transactions, including Silence Therapeutics' $1.3 billion acquisition by Merck KGaA and Option Care Health's $5.8 billion deal with CD&R and McKesson. Investors owning shares in these companies are encouraged to contact Brodsky & Smith for more information, with no cost or obligation involved.
The Brodsky & Smith shareholder update on investigations into several companies' merger deals is provided here with Pluang's health sector market data as of Oct 20, 2026 19:03 WIB. Of 150 priced health-sector US stocks tradable on Pluang, 81 rose and 62 fell today. Notable movers include Alcon AG (ALC) at USD 67.41 with a 1-day change of +1.94% and 100% buy order activity, Nuvation Bio Inc. Class A (NUVB) at USD 4.40 down 1.79%, and 10X Genomics Inc (TXG) at USD 68.65 down 1.77% with 100% sell order activity. The most notable figure is Alcon AG's 100% buy order activity on Pluang.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
